Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

Zomedica wraps up 2017 with several milestone achievements for pipeline

US animal health firm Zomedica Pharmaceuticals has achieved a number of milestones for its pet therapeutics pipeline in 2017. 

R&D Pharmaceuticals

European boost for Australian cannabis treatment firm

Australian animal health company CannPal has seen its European business prospects boosted with the granting of a small and medium size enterprise status (SME) by the European Medicines Agency (EMA). 

R&D Pain

Krka makes progress with marketing authorizations

Slovenian animal health company Krka said it has obtained marketing authorization for several new products in the first nine months of fiscal 2017.

Slovenia Europe

ECO gets Canadian green light for Aivlosin

UK company ECO Animal Health has received marketing authorization for its lead product Aivlosin in Canada.

North America United States

Benchmark upbeat over sea lice product trials

US aquaculture health and genetics company Benchmark said commercial scale trials have proved a success for its sea lice treatment Ectosan.

Europe Norway

Pre-clinical study backs Panion's canine epilepsy treatment

A study of Swedish gene therapy firm Panion's epilepsy drug candidate has shown positive initial results. 

Europe Denmark

Zoetis, Huvepharma gain approvals in US

Zoetis has received two supplemental approvals from the US FDA. 

North America United States

Aivlosin drives ECO to positive first half

UK firm ECO Animal Health has seen a strong 8% increase in revenues during the first half of its fiscal 2017. 

Europe United Kingdom

Oasmia to list veterinary assets on Nasdaq under AdvaVet

Swedish firm Oasmia Pharmaceuticals is aiming to list its veterinary assets on the Nasdaq through its wholly-owned US subsidiary. 

Companion Animals Operations

Sharp drop in US use of antibiotics in livestock

The US has seen the sale and distribution of antibiotics approved for use in food-producing animals in the country decrease by 10% from 2015 to 2016. 

FDA Pharmaceuticals

Norbrook study shows preference for liquid hyperthyroidism solution

Norbrook Laboratories has found cat owners prefer the new liquid form of its feline medicine Thyronorm. 

Norbrook Laboratories Pharmaceuticals

Norbrook global strategy keeps up strong revenue momentum

For the third year running the UK's second largest animal health company Norbrook Laboratories has produced strong revenue results. 

Norbrook Laboratories Financial Results
See All